Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

For decades, cancer patients have been told that shrinking tumors meant accepting brutal side effects as the price of ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...

On August 8, 2025, the FDA granted accelerated approval to zongertinib for adult patients with unresectable or metastatic ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Acquisition brings an advanced, highly differentiated treatment for prostate cancer, strengthening Johnson & Johnson's longstanding commitment to innovation in the disease Lead asset demonstrates pote ...

Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the successful completion of its acquisition of Halda Therapeutics OpCo, Inc. (“Halda”), a clinical-stage biotechnology company with a ...

Researchers in Australia have developed metallic nano dots that selectively destroy cancer cells by increasing cellular stress without harming healthy tissue.

Researchers at RMIT University in Melbourne have developed minuscule 'nanodots' that show promise for future targeted cancer ...